Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3551
Opko Health
OPK
$1.27B
| $400K | ﹤0.01% |
248,608
+149,012
| +150% | +$216K |
2013 Q2
53 quarters
|
|
3552
Dakota Gold
DC
$780M
| $400K | ﹤0.01% |
65,716
+38,043
| +137% | +$209K |
2022 Q2
17 quarters
|
|
3553
Information Services Group
III
$298M
| $400K | ﹤0.01% |
72,271
+3,008
| +4% | +$14.2K |
2019 Q1
30 quarters
|
|
3554
Clarivate
CLVT
$1.49B
| $399K | ﹤0.01% |
239,075
+57,352
| +32% | +$117K |
2019 Q3
28 quarters
|
|
3555
Red River Bancshares
RRBI
$689M
| $397K | ﹤0.01% |
3,979
-1,093
| -22% | -$110K |
2019 Q2
29 quarters
|
|
3556
Foster
FSTR
$446M
| $397K | ﹤0.01% |
10,998
+2,687
| +32% | +$106K |
2013 Q2
53 quarters
|
|
3557
Assembly Biosciences
ASMB
$457M
| $396K | ﹤0.01% |
16,838
+10,705
| +175% | +$306K |
2017 Q1
38 quarters
|
|
3558
MakeMyTrip
MMYT
$4.95B
| $394K | ﹤0.01% |
8,356
-8,480
| -50% | -$469K |
2025 Q2
5 quarters
|
|
3559
NPK International
NPKI
$782M
| $393K | ﹤0.01% |
34,444
+14,723
| +75% | +$198K |
2016 Q2
41 quarters
|
|
3560
Phibro Animal Health
PAHC
$1.42B
| $392K | ﹤0.01% |
10,974
-2,979
| -21% | -$105K |
2014 Q2
49 quarters
|
|
3561
Inhibrx
INBX
$1.33B
| $392K | ﹤0.01% |
3,918
+1,571
| +67% | +$157K |
2024 Q2
9 quarters
|
|
3562
Security National Financial
SNFCA
$235M
| $392K | ﹤0.01% |
45,058
+4,188
| +10% | +$38.3K |
2020 Q2
25 quarters
|
|
3563
Kopin
KOPN
$668M
| $391K | ﹤0.01% |
85,055
+56,190
| +195% | +$244K |
2024 Q4
7 quarters
|
|
3564
Graham Corp
GHM
$1.03B
| $390K | ﹤0.01% |
4,521
+2,819
| +166% | +$277K |
2023 Q3
12 quarters
|
|
3565
American Battery Technology Co
ABAT
$191M
| $390K | ﹤0.01% |
176,437
+155,796
| +755% | +$381K |
2025 Q1
6 quarters
|
|
3566
Oric Pharmaceuticals
ORIC
$934M
| $389K | ﹤0.01% |
28,848
+9,041
| +46% | +$113K |
2023 Q2
13 quarters
|
|
3567
National Presto Industries
NPK
$1.03B
| $385K | ﹤0.01% |
2,600
+912
| +54% | +$126K |
2016 Q3
40 quarters
|
|
3568
OneSpan
OSPN
$818M
| $385K | ﹤0.01% |
21,470
+9,138
| +74% | +$148K |
2022 Q1
18 quarters
|
|
3569
Target Hospitality
TH
$1.15B
| $383K | ﹤0.01% |
19,428
+11,382
| +141% | +$203K |
2019 Q1
30 quarters
|
|
3570
Star Bulk Carriers
SBLK
$3.24B
| $380K | ﹤0.01% |
12,947
+3,914
| +43% | +$113K |
2026 Q1
2 quarters
|
|
3571
CALL
TE Connectivity
TEL
$63.1B
| $380K | ﹤0.01% |
+1,800
| New | +$372K |
2026 Q3
0 quarters
|
|
3572
Xponential Fitness
XPOF
$201M
| $380K | ﹤0.01% |
84,363
+36,543
| +76% | +$198K |
2022 Q1
18 quarters
|
|
3573
Digimarc Corp
DMRC
$177M
| $379K | ﹤0.01% |
65,080
+62,868
| +2,842% | +$391K |
2016 Q3
40 quarters
|
|
3574
Genmab
GMAB
$33B
| $379K | ﹤0.01% |
10,617
+10,457
| +6,536% | +$331K |
2022 Q1
18 quarters
|
|
3575
CEVA Inc
CEVA
$755M
| $378K | ﹤0.01% |
10,706
-12,396
| -54% | -$417K |
2013 Q2
53 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.